Nurix Therapeutics, Inc. (NRIX) short interest & options flow
NASDAQNurix Therapeutics enters November with a notable contradiction: short sellers hold 20% of the free float, yet options traders have rarely looked more bullish. Short interest at 20.2% of free float is genuinely elevated. It climbed roughly 3 percentage points through late October, jumping from around 17.5% to current levels in a single week at the end of October. FINRA's…
NRIX cost to borrow surges to 1.91%, up 282% in one week amid tight share availability and sustained short pressure.
- Market cap
- $1.73B
- Next earnings
- 28 Jan 2027
Key data as of 11 Nov 2026

NRIX news and analysis
RSSNo long-form analysis yet for NRIX. Pulse alerts and the live data picture are available on ORTEX.
Open NRIX on ORTEX →Want the live picture for NRIX?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NRIX — free to start on ORTEX.
Sign up for free →Open NRIX on ORTEX